AFP DEPARTMENT COLLECTION
Practice Guidelines summarize important clinical recommendations from major medical organizations and the federal government.
Aug 1, 2010 Issue
ACOG Guidelines on Noncontraceptive Uses of Hormonal Contraceptives
Many of women use hormonal contraception for its noncontraceptive benefits, such as making menstruation more predictable and correcting menstrual irregularities caused by oligo-ovulation or anovulation. The American College of Obstetricians and Gynecologists (ACOG) provides guidelines on these noncontraceptive uses.
Jul 15, 2010 Issue
ADA Releases Updated Recommendations on Standards of Medical Care in Diabetes
The 2010 American Diabetes Association's (ADA) “Standards of Medical Care in Diabetes” includes revisions based on new evidence. Several sections have undergone major changes.
Jul 1, 2010 Issue
AGS Releases Guideline for Prevention of Falls in Older Persons
Recommendations from the American Geriatrics Society (AGS) guide physicians in screening older patients for risk of falling and preventing falls among those at increased risk.
Jun 15, 2010 Issue
International Consensus Group Issues Recommendations for Management of Upper GI Bleeding
In response to new data that may lead to improved patient outcomes, the International Consensus Upper Gastrointestinal Bleeding Conference Group—a multidisciplinary group of 34 experts from 15 countries—developed international guidelines for managing nonvariceal upper GI bleeding. The guidelines include new recommendations, as well as updates to the 2002 guidelines from the British Society of Gastroenterology and the 2003 consensus guidelines from the Nonvariceal Upper GI Bleeding Consensus Conference Group.
Jun 1, 2010 Issue
ACOG Updates Guidelines on Cervical Cytology Screening
One approach to further reduce the incidence of cervical cancer is to increase screening rates among women who have never been screened or who are screened infrequently. The American College of Obstetricians and Gynecologists (ACOG) recently updated its recommendations on screening for cervical cancer, including screening intervals.
May 15, 2010 Issue
Guidelines for the Diagnosis and Management of Hoarseness
The American Academy of Otolaryngology–Head and Neck Surgery Foundation has released evidence-based guidelines for the evaluation and management of hoarseness. The goals of the guidelines are to improve diagnostic accuracy; reduce inappropriate medication and imaging use; and promote appropriate use of laryngoscopy, voice therapy, and surgery.
May 1, 2010 Issue
ACP Releases Guideline on Hormone Testing and Pharmacologic Treatment of Erectile Dysfunction
As the general population ages and life expectancy increases, erectile dysfunction (ED) is anticipated to be a major health care burden. Therefore, the American College of Physicians (ACP) created a guideline on hormone testing and pharmacologic treatment of ED.
Apr 15, 2010 Issue
ACEP Releases Guidelines on Evaluation of Suspected Acute Appendicitis
The American College of Emergency Physicians (ACEP) has developed evidence-based recommendations to help physicians judge which clinical findings are most useful for guiding decision making in patients with suspected acute appendicitis. The guidelines also address the use of contrast dye in imaging and the choice of imaging modality in children.
Apr 1, 2010 Issue
ACOG Guidelines on Pregnancy After Bariatric Surgery
Counseling and treating women who become pregnant after bariatric surgery present unique challenges. Although outcomes are generally good, nutritional and surgical complications can arise. The American College of Obstetricians and Gynecologists (ACOG) recently reviewed the available evidence on pregnancy outcomes after bariatric surgery.
Mar 15, 2010 Issue
ASCO Updates Guideline on the Use of Pharmacologic Interventions to Reduce Breast Cancer Risk
The American Society of Clinical Oncology's (ASCO) updated guideline addresses: (1) the use of tamoxifen, raloxifene (Evista), aromatase inhibitors, and fenretinide (not available in the United States) versus no pharmacologic intervention to reduce the risk of breast cancer; (2) the comparative effectiveness of tamoxifen, raloxifene, aromatase inhibitors, and fenretinide; and (3) effective and responsible communication between physicians and patients about breast cancer risk reduction in women eligible to consider use of these agents.